0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover601.21%IV-84.83%PremiumDec 20, 2024Expiry Date13.98Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9758Delta0.0021Gamma1.14Leverage Ratio-0.0287Theta0.0012Rho1.11Eff Leverage0.0025Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet